| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99051 |
|
38,445 |
33,678 |
$1.76M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
447 |
426 |
$14K |
| 71046 |
Radiologic examination, chest; 2 views |
694 |
596 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
502 |
365 |
$5K |
| 74018 |
|
506 |
384 |
$5K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
42 |
34 |
$2K |
| 70260 |
|
121 |
98 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
227 |
220 |
$2K |
| 73560 |
|
82 |
64 |
$1K |
| 73620 |
|
23 |
14 |
$475.16 |
| 73120 |
|
15 |
13 |
$333.55 |
| 70210 |
|
21 |
12 |
$205.61 |
| 73610 |
|
24 |
24 |
$194.83 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
234 |
229 |
$140.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
190 |
119 |
$30.52 |
| 36415 |
Collection of venous blood by venipuncture |
53 |
52 |
$18.00 |
| 81001 |
|
332 |
323 |
$8.65 |
| 86701 |
|
70 |
69 |
$0.00 |
| 1125F |
|
504 |
430 |
$0.00 |
| 3008F |
|
1,326 |
933 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
36 |
34 |
$0.00 |
| 80069 |
|
13 |
13 |
$0.00 |
| 86803 |
|
69 |
68 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
309 |
300 |
$0.00 |
| 82607 |
|
16 |
15 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
61 |
60 |
$0.00 |
| 2000F |
|
430 |
412 |
$0.00 |
| 2001F |
|
407 |
390 |
$0.00 |
| 1170F |
|
54 |
43 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
28 |
27 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
281 |
273 |
$0.00 |
| 1111F |
|
88 |
70 |
$0.00 |
| 3079F |
|
87 |
85 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
373 |
360 |
$0.00 |
| 3075F |
|
28 |
28 |
$0.00 |
| 85651 |
|
14 |
12 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
189 |
184 |
$0.00 |
| 3074F |
|
630 |
556 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
123 |
121 |
$0.00 |
| 1126F |
|
422 |
393 |
$0.00 |
| 1123F |
|
27 |
27 |
$0.00 |
| 87088 |
|
15 |
15 |
$0.00 |
| 99217 |
|
13 |
13 |
$0.00 |
| 86592 |
|
46 |
46 |
$0.00 |
| 86702 |
|
67 |
66 |
$0.00 |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13 |
12 |
$0.00 |
| 84153 |
|
17 |
17 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12 |
12 |
$0.00 |
| 82040 |
|
20 |
20 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$0.00 |
| 82043 |
|
41 |
39 |
$0.00 |
| 86738 |
|
13 |
13 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
30 |
30 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
22 |
20 |
$0.00 |
| 3078F |
|
628 |
563 |
$0.00 |
| 1159F |
|
377 |
213 |
$0.00 |
| 82570 |
|
45 |
44 |
$0.00 |
| 3725F |
|
459 |
380 |
$0.00 |
| 80061 |
Lipid panel |
315 |
308 |
$0.00 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
83 |
83 |
$0.00 |
| 99497 |
|
144 |
135 |
$0.00 |
| 1160F |
|
255 |
210 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
17 |
16 |
$0.00 |
| 87400 |
|
15 |
14 |
$0.00 |
| 84156 |
|
12 |
12 |
$0.00 |
| 99218 |
|
13 |
13 |
$0.00 |
| 82274 |
|
21 |
21 |
$0.00 |
| G9316 |
Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family |
15 |
15 |
$0.00 |
| 84439 |
|
36 |
36 |
$0.00 |
| 3077F |
|
41 |
40 |
$0.00 |
| 84550 |
|
12 |
12 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
34 |
34 |
$0.00 |